Notice - Prescription Drug List (PDL): Levonorgestrel

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for levonorgestrel on the Prescription Drug List (PDL). Only the Human part of the PDL was revised; the listing for Veterinary use will remain unchanged.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Avis - Liste des drogues sur ordonnance (LDO) : Lévonorgestrel
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2017-05-18 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["Lévonorgestrel", "avis", "avis de modification", "liste des médicaments sur ordonnance", "LPD", "liste révisée", "statut de vente en vente libre", "usage humain", "Liste des médicaments sur ordonnance chez les humains", "usage vétérinaire inchangé"], "en": ["Levonorgestrel", "notice", "notice of amendment", "prescription drug list", "PDL", "revised listing", "nonprescription status", "human use", "Human Prescription Drug-List", "Veterinary use unchanged"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source